Patents Assigned to RIBONOVA INC.
  • Methods of Treating Mitochondrial Dysfunction
    Publication number: 20250000817
    Abstract: This disclosure is directed to methods of treating or preventing mitochondrial dysfunction or mitochondrial disease in a subject comprising administration of probucol, or a pharmaceutically acceptable salt thereof. This disclosure is also directed to methods of diagnosing genetic mitochondrial disease in a subject prior to and in association with said treatment or prevention. This disclosure is also directed to methods of assessing and managing a subject with mitochondrial dysfunction or mitochondrial disease using a composite measurement.
    Type: Application
    Filed: August 5, 2024
    Publication date: January 2, 2025
    Applicant: RIBONOVA INC.
    Inventors: Marni J. Falk, Shana E. McCormack, Zaraxuela Zolkipli-Cunningham, Nigel L. Webb, Eric C. Yuen, Anthony W. Ford-Hutchinson
  • Systems and Methods for Computing Measurements for Mitochondrial Diseases
    Publication number: 20210375467
    Abstract: This disclosure is directed to methods of methods of computing a composite measurement comprising employing two or more sub-instruments to measure one or more clinical symptoms of mitochondrial dysfunction or mitochondrial disease. This disclosure is also directed to methods of assessing and managing a subject with mitochondrial dysfunction or mitochondrial disease using a composite measurement.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 2, 2021
    Applicants: RIBONOVA INC., The Children's Hospital of Philadelphia
    Inventors: Marni J. Falk, Nigel L. Webb, Shana E. McCormack, Eric C. Yuen, Zarazuela Zolkipli-Cunningham, Anthony W. Ford-Hutchinson
  • Methods of Treating Mitochondrial Dysfunction
    Publication number: 20210283072
    Abstract: This disclosure is directed to methods of treating or preventing mitochondrial dysfunction or mitochondrial disease in a subject comprising administration of probucol, or a pharmaceutically acceptable salt thereof. This disclosure is also directed to methods of diagnosing genetic mitochondrial disease in a subject prior to and in association with said treatment or prevention. This disclosure is also directed to methods of assessing and managing a subject with mitochondrial dysfunction or mitochondrial disease using a composite measurement.
    Type: Application
    Filed: June 26, 2019
    Publication date: September 16, 2021
    Applicant: RIBONOVA INC.
    Inventors: Marni J. Falk, Shana E. McCormack, Zaraxuela Zolkipli-Cunningham, Nigel L. Webb, Eric C. Yuen, Anthony W. Ford-Hutchinson